SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form 8-K - Current report:
SEC Accession No. 0001607062-21-000363
Filing Date
2021-09-28
Accepted
2021-09-28 09:00:25
Documents
13
Period of Report
2021-09-28
Items
Item 7.01: Regulation FD Disclosure
Item 9.01: Financial Statements and Exhibits

Document Format Files

Seq Description Document Type Size
1 8-K nptx092721form8k.htm   iXBRL 8-K 33506
2 EXHIBIT 99.1 ex99_1.htm EX-99.1 22159
  Complete submission text file 0001607062-21-000363.txt   231636

Data Files

Seq Description Document Type Size
3 XBRL SCHEMA FILE nptx-20210928.xsd EX-101.SCH 3034
4 XBRL LABEL FILE nptx-20210928_lab.xml EX-101.LAB 34240
5 XBRL PRESENTATION FILE nptx-20210928_pre.xml EX-101.PRE 22365
6 EXTRACTED XBRL INSTANCE DOCUMENT nptx092721form8k_htm.xml XML 3274
Mailing Address 3805 OLD EASTON ROAD DOYLESTOWN PA 18902
Business Address 3805 OLD EASTON ROAD DOYLESTOWN PA 18902 858-883-2642
NEUROPATHIX, INC. (Filer) CIK: 0001615999 (see all company filings)

IRS No.: 462645343 | State of Incorp.: DE | Fiscal Year End: 1231
Type: 8-K | Act: 34 | File No.: 000-55657 | Film No.: 211283824
SIC: 2834 Pharmaceutical Preparations